Mylan says it will make available a generic version of its EpiPen,
as criticism mounts over the price of its injectable medicine.
The company said Monday that its U.S. subsidiary
will put out a generic version of the EpiPen that will have a list
price of $300 for a two-pack — about half the current price. It will be
available in both 0.15 mg and 0.30 mg strengths.
EpiPens are used in emergencies to treat severe allergies to insect
bites and foods like nuts and eggs that can lead to anaphylactic shock.
Click here for the full article.
No comments:
Post a Comment